Large-scale testing (Phase 3)Study completedNCT03691831What this trial is testingA-101 Topical Solution for the Treatment of Common WartsWho this might be right forCommon Wart Aclaris Therapeutics, Inc. 502
Testing effectiveness (Phase 2)UnknownNCT04647695What this trial is testingIFN-beta 1b and Remdesivir for COVID19Who this might be right forCovid19 The University of Hong Kong 100
Not applicableStudy completedNCT04478539What this trial is testingExtracorporeal Blood Purification as a Treatment Modality for COVID-19Who this might be right forCovid19 Zan Mitrev Clinic 35
Testing effectiveness (Phase 2)Ended earlyNCT00865566What this trial is testingSafety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With MenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 2,504
Testing effectiveness (Phase 2)Study completedNCT05442983What this trial is testingEvaluate the Efficacy of PanCytoVir™ for the Treatment of Non-Hospitalized Patients With COVID-19 InfectionWho this might be right forCOVID-19 TrippBio, Inc. 75
Large-scale testing (Phase 3)UnknownNCT04323345What this trial is testingEfficacy of Natural Honey Treatment in Patients With Novel CoronavirusWho this might be right forCOVID-19 Misr University for Science and Technology 1,000
Large-scale testing (Phase 3)Study completedNCT03222583What this trial is testingEvaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionWho this might be right forHepatitis C Virus (HCV) AbbVie 546
Early research (Phase 1)WithdrawnNCT05609045What this trial is testingA Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as BoosterWho this might be right forCOVID-19 Pandemic Wuhan Rhegen Biotechnology Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT01418937What this trial is testingSafety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 StudyWho this might be right forInfections, Papillomavirus GlaxoSmithKline 164
Testing effectiveness (Phase 2)Ended earlyNCT04900428What this trial is testingStudy to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)Who this might be right forCovid19 Sorrento Therapeutics, Inc. 179
Large-scale testing (Phase 3)Ended earlyNCT01718301What this trial is testingHIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /RibavirinWho this might be right forHepatitis CHIV InfectionsCOINFECTION Anna Cruceta 108
Not applicableStudy completedNCT01671501What this trial is testingPrimary Care-Based Interventions to Reduce Alcohol Use Among HIV PatientsWho this might be right forHIVAcquired Immunodeficiency SyndromeAlcoholism+2 more University of California, San Francisco 614
Not applicableUnknownNCT00974519What this trial is testingThe Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS PatientsWho this might be right forAcquired Immune Deficiency Syndrome VirusHIV Infections Guang'anmen Hospital of China Academy of Chinese Medical Sciences 180
Large-scale testing (Phase 3)Study completedNCT00004757What this trial is testingPhase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and MouthWho this might be right forHerpes Simplex National Center for Research Resources (NCRR)
Not applicableStudy completedNCT05244044What this trial is testingPulmonary Rehabilitation for Long COVID (Post COVID-19 Condition)Who this might be right forCOVID-19Long COVIDPost COVID-19 Condition University Hospital, Antwerp 76
Testing effectiveness (Phase 2)Study completedNCT04401202What this trial is testingNigella Sativa in COVID-19Who this might be right forCOVID-19SARS-CoV-2 King Abdulaziz University 183
Testing effectiveness (Phase 2)Ended earlyNCT00508651What this trial is testingA Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of AgeWho this might be right forHealthy MedImmune LLC 30
Large-scale testing (Phase 3)Study completedNCT01825031What this trial is testingReduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral TherapyWho this might be right forHuman Immunodeficiency Virus Anna Griffiths, MRC 1,805
Testing effectiveness (Phase 2)Study completedNCT04311177What this trial is testingLosartan for Patients With COVID-19 Not Requiring HospitalizationWho this might be right forCorona Virus InfectionAcute Respiratory Distress SyndromeSARS-CoV Infection University of Minnesota 117
Large-scale testing (Phase 3)Study completedNCT02810275What this trial is testingFolinic Acid: Supplementation and TherapyWho this might be right forHIV InfectionHCV Coinfection Hospital de Clinicas de Porto Alegre 69